{
    "2020-04-06": [
        [
            {
                "time": "",
                "original_text": "【东兴医药胡博新团队】天坛生物（600161）：19年业绩稳步增长，新品研发和产能扩展强化规模优势",
                "features": {
                    "keywords": [
                        "天坛生物",
                        "业绩稳步增长",
                        "新品研发",
                        "产能扩展",
                        "规模优势"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}